股票行情快报：祥生医疗（688358）2月5日主力资金净卖出9.33万元

Core Viewpoint - Xiangsheng Medical (688358) has experienced a decline in stock price and financial performance, with a focus on its ultrasound medical imaging equipment business [1] Financial Performance - As of February 5, 2026, Xiangsheng Medical's stock closed at 35.6 yuan, down 0.95%, with a trading volume of 9,475 lots and a transaction amount of 33.89 million yuan [1] - For the first three quarters of 2025, the company reported a main revenue of 343 million yuan, a year-on-year decrease of 5.27%, and a net profit attributable to shareholders of 93.92 million yuan, down 4.56% [1] - In Q3 2025, the company recorded a single-quarter main revenue of 107 million yuan, a year-on-year decrease of 6.68%, while the net profit attributable to shareholders increased by 41.95% to 24.22 million yuan [1] - The company's gross profit margin stands at 59.82%, with a debt ratio of 11.24% [1] Investment Ratings - In the last 90 days, three institutions have given buy ratings for Xiangsheng Medical [2]